Award to support the development of molecules to inhibit BamA protein Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award a seed grant of US$610k to Justus Liebig ...

Transformative Scientific Breakthrough Pioneered by Spencer Trask & Co. Venture Osiris Therapeutics NEW YORK, Jan. 16, 2025 ...

Science is ever-evolving, and with it, our understanding of the world around us. Many long-held beliefs have been debunked by ...

An Israeli Palestinian team from the Hebrew University of Jerusalem develops novel metamaterials for process of sustainable ...

The new molecules target a metabolic pathway that only occurs in bacterial cells, thus sparing human cells. The team ...

Antibiotics are a double-edged sword—they should be as toxic as possible to pathogenic bacteria while being harmless to the ...

Antibiotics are a double-edged sword – they should be as toxic as possible to pathogenic bacteria while being harmless to the cells of the human body. An international research team led by the ...

Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) ...

Objectives In the intensive care unit (ICU), antibiotics are often given longer than recommended in guidelines ... ICU should prioritise strengthening interdisciplinary communication between ...

Antibiotics are ineffective against viral infections like human metapneumovirus (HMPV). HMPV affects the respiratory system, and antibiotics, designed ...

Clarametyx Biosciences will receive $2.6 million from CARB-X to develop CMTX-301, a vaccine designed to prevent bacterial ...